Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants

Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants

Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants In a recent Morbidity and Mortality Weekly Report published by the United States Centers for Disease Control and Prevention (CDC), researchers discuss the efficacy of the bivalent coronavirus disease 2019 (COVID-19) vaccine against symptomatic infection with several SARS-CoV-2 variants that are currently circulating throughout the U.S. Study: Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adult …